Lupin receives USFDA's approval for generic Hydrocortisone Butyrate Lotion

21 Aug 2018 Evaluate

Lupin has received final approval for its Hydrocortisone Butyrate Lotion, 0.1% from the United States Food and Drug Administration (USFDA) to market a generic version of PreCision Dermatology, Inc.'s (PreCision) Locoid Lotion, 0.1%.

Lupin's Hydrocortisone Butyrate Lotion, 0.1% is the generic version of PreCision's Locoid Lotion, 0.1%. It is a corticosteroid indicated for the topical treatment of mild to moderate atopic dermatitis in patients 3 months of age and older. Hydrocortisone Butyrate Lotion, 0.1% had annual sales of approximately $13.8million in the US (IQVIA MAT April 2018).

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2101.60 -4.25 (-0.20%)
05-Jan-2026 11:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1731.45
Dr. Reddys Lab 1255.80
Cipla 1521.00
Zydus Lifesciences 922.05
Lupin 2101.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×